Gene Silencing of the Mitochondrial Adaptor p66Shc Suppresses Vascular Hyperglycemic Memory in Diabetes

被引:218
作者
Paneni, Francesco [1 ,2 ]
Mocharla, Pavani [1 ,3 ,4 ]
Akhmedov, Alexander [1 ,3 ,4 ]
Costantino, Sarah [1 ,5 ]
Osto, Elena [1 ,3 ,4 ]
Volpe, Massimo [2 ,6 ]
Luescher, Thomas Felix [1 ,3 ,4 ]
Cosentino, Francesco [1 ,3 ,4 ,6 ]
机构
[1] Univ Zurich, Inst Physiol, CH-8006 Zurich, Switzerland
[2] IRCCS Neuromed, Pozzilli, Italy
[3] Univ Zurich Hosp, Ctr Cardiovasc, CH-8091 Zurich, Switzerland
[4] Univ Zurich, Ctr Integrat Human Physiol, CH-8006 Zurich, Switzerland
[5] Univ Naples 2, Pharmacol Sect, Dept Expt Med, Naples, Italy
[6] Univ Rome Sapienza, Dept Clin & Mol Med, Rome, Italy
基金
新加坡国家研究基金会;
关键词
vascular disease; diabetes mellitus; free radicals; endothelium; KINASE-C-BETA; OXIDATIVE STRESS; NITRIC-OXIDE; HIGH-GLUCOSE; CARDIOVASCULAR-DISEASE; GLYCEMIC CONTROL; LONGEVITY GENE; LIFE-SPAN; PHOSPHORYLATION; EXPRESSION;
D O I
10.1161/CIRCRESAHA.112.266593
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Rationale: Hyperglycemic memory may explain why intensive glucose control has failed to improve cardiovascular outcomes in patients with diabetes. Indeed, hyperglycemia promotes vascular dysfunction even after glucose normalization. However, the molecular mechanisms of this phenomenon remain to be elucidated. Objective: The present study investigated the role of mitochondrial adaptor p66(Shc) in this setting. Methods and Results: In human aortic endothelial cells (HAECs) exposed to high glucose and aortas of diabetic mice, activation of p66(Shc) by protein kinase C beta II (PKC beta II) persisted after returning to normoglycemia. Persistent p66(Shc) upregulation and mitochondrial translocation were associated with continued reactive oxygen species (ROS) production, reduced nitric oxide bioavailability, and apoptosis. We show that p66(Shc) gene overexpression was epigenetically regulated by promoter CpG hypomethylation and general control nonderepressible 5-induced histone 3 acetylation. Furthermore, p66(Shc)-derived ROS production maintained PKC beta II upregulation and PKC beta II-dependent inhibitory phosphorylation of endothelial nitric oxide synthase at Thr-495, leading to a detrimental vicious cycle despite restoration of normoglycemia. Moreover, p66(Shc) activation accounted for the persistent elevation of the advanced glycated end product precursor methylglyoxal. In vitro and in vivo gene silencing of p66(Shc), performed at the time of glucose normalization, blunted ROS production, restored endothelium-dependent vasorelaxation, and attenuated apoptosis by limiting cytochrome c release, caspase 3 activity, and cleavage of poly (ADP-ribose) polymerase. Conclusions: p66(Shc) is the key effector driving vascular hyperglycemic memory in diabetes. Our study provides molecular insights for the progression of diabetic vascular complications despite glycemic control and may help to define novel therapeutic targets. (Circ Res. 2012;111:278-289)
引用
收藏
页码:278 / +
页数:26
相关论文
共 53 条
[1]   Chemistry, physiology and pathology of free radicals [J].
Bergendi, L ;
Benes, L ;
Duracková, Z ;
Ferencik, M .
LIFE SCIENCES, 1999, 65 (18-19) :1865-1874
[2]  
Bonati A, 2000, CANCER RES, V60, P728
[3]   Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trials [J].
Boussageon, Remy ;
Bejan-Angoulvant, Theodora ;
Saadatian-Elahi, Mitra ;
Lafont, Sandrine ;
Bergeonneau, Claire ;
Kassai, Behrouz ;
Erpeldinger, Sylvie ;
Wright, James M. ;
Gueyffier, Francois ;
Cornu, Catherine .
BMJ-BRITISH MEDICAL JOURNAL, 2011, 343
[4]   Hyperglycaemia-induced impairment of endothelium-dependent vasorelaxation in rat mesenteric arteries is mediated by intracellular methylglyoxal levels in a pathway dependent on oxidative stress [J].
Brouwers, O. ;
Niessen, P. M. ;
Haenen, G. ;
Miyata, T. ;
Brownlee, M. ;
Stehouwer, C. D. ;
De Mey, J. G. ;
Schalkwijk, C. G. .
DIABETOLOGIA, 2010, 53 (05) :989-1000
[5]   Intensive glycemic control and cardiovascular disease: an update [J].
Brown, Aparna ;
Reynolds, L. Raymond ;
Bruemmer, Dennis .
NATURE REVIEWS CARDIOLOGY, 2010, 7 (07) :369-375
[6]   AGE-receptor-1 counteracts cellular oxidant stress induced by AGEs via negative regulation of p66shc-dependent FKHRL1 phosphorylation [J].
Cai, Weijing ;
He, John Cijiang ;
Zhu, Li ;
Chen, Xue ;
Striker, Gary E. ;
Vlassara, Helen .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2008, 294 (01) :C145-C152
[7]   Genetic deletion of p66Shc adaptor protein prevents hyperglycemia-induced endothelial dysfunction and oxidative stress [J].
Camici, Giovanni G. ;
Schiavoni, Marzia ;
Francia, Pietro ;
Bachschmid, Markus ;
Martin-Padura, Ines ;
Hersberger, Martin ;
Tanner, Felix C. ;
Pelicci, PierGiuseppe ;
Volpe, Massimo ;
Anversa, Piero ;
Luescher, Thomas F. ;
Cosentino, Francesco .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (12) :5217-5222
[8]   Simultaneous control of hyperglycemia and oxidative stress normalizes endothelial function in type 1 diabetes [J].
Ceriello, Antonio ;
Kumar, Sudhesh ;
Piconi, Ludovica ;
Esposito, Katerine ;
Giugliano, Dario .
DIABETES CARE, 2007, 30 (03) :649-654
[9]   UKPDS and the legacy effect [J].
Chalmers, John ;
Cooper, Mark E. .
NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (15) :1618-1620
[10]   Epigenetics Mechanisms and Implications for Diabetic Complications [J].
Cooper, Mark E. ;
El-Osta, Assam .
CIRCULATION RESEARCH, 2010, 107 (12) :1403-1413